Cargando…

Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases

Detalles Bibliográficos
Autores principales:	Brumfiel, Caitlin M., Saardi, Karl M., Ronkainen, Sanna D., Shenoy, Aarthi G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452245/ https://www.ncbi.nlm.nih.gov/pubmed/32875042 http://dx.doi.org/10.1016/j.jdcr.2020.07.005

Ejemplares similares

Alemtuzumab in refractory Sézary syndrome
por: Reifs, Carmen María Alcántara, et al.
Publicado: (2016)

Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome
por: Breen, Ilana D., et al.
Publicado: (2021)

Dupilumab-Associated Sezary Syndrome
por: Hamp, Austin, et al.
Publicado: (2023)

Alemtuzumab: Infections: 4 case reports
Publicado: (2020)

Alemtuzumab: Haemophagocytic lymphohistiocytosis: case report
Publicado: (2021)

Alemtuzumab: COVID-19 infection: case report
Publicado: (2020)

Pembrolizumab-associated tumor development in a patient with Sézary syndrome
por: Malachowski, Stephen J., et al.
Publicado: (2019)

Sezary syndrome, thyroid carcinoma, and renal carcinoma in a patient with Poland syndrome
por: Kuzyk, Alexandra, et al.
Publicado: (2021)

Successful treatment of Sezary syndrome with extracorporeal photopheresis – The first attempt in India
por: Tiwari, Aseem K., et al.
Publicado: (2019)

Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
por: Kanda-Kato, Madoka, et al.
Publicado: (2020)

A rare association of bullous pemphigoid with mycosis fungoides and Sézary syndrome
por: Egger, Andjela, et al.
Publicado: (2020)

Partial remission of advanced untreated Sézary syndrome after COVID-19
por: Snowden, Caroline, et al.
Publicado: (2022)

Alemtuzumab-associated diffuse alveolar damage – a case report
por: Bayas, Antonios, et al.
Publicado: (2020)

Alemtuzumab/methylprednisolone: Coronavirus disease-2019: 2 case reports
Publicado: (2020)

Alemtuzumab/natalizumab/ocrelizumab: COVID-19: 3 case reports
Publicado: (2021)

Plantar keratoderma of Sézary syndrome
por: Fragkos, Konstantinos C.
Publicado: (2017)

Mycosis fungoides and Sézary syndrome
por: Jonak, Constanze, et al.
Publicado: (2021)

Mycosis fungoides and Sézary syndrome
por: Lee, Hyewon
Publicado: (2023)

Alemtuzumab: COVID-19 infection and severe depletion of T-lymphocyte: case report
Publicado: (2020)

Alemtuzumab/cladribine/natalizumab: Lymphopenia and COVID-19 infection: case report
Publicado: (2021)

Occurrence of Sézary syndrome following the initiation of anti-IL-5 treatment
por: Barré, Mathilde, et al.
Publicado: (2022)

Reactive Langerhans Cell Proliferation Mimicking Langerhans Cell Histiocytosis in Association with Sézary Syndrome: A Case Report and Literature Review
por: Zhang, Jinjing, et al.
Publicado: (2021)

Hepatic Infiltration with Malignant T-cells Manifesting as Impending Acute Liver Failure in Sezary Syndrome
por: Zhang, Yumeng, et al.
Publicado: (2020)

Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome
por: Moerman-Herzog, Andrea, et al.
Publicado: (2020)

Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy
por: Vališ, Martin, et al.
Publicado: (2020)

COVID-19 infection in patients with Sézary syndrome: report of three cases
por: Granara, Martina, et al.
Publicado: (2021)

Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases
por: Rau, Daniela, et al.
Publicado: (2015)

Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome
por: Maredia, Hasina, et al.
Publicado: (2021)

Integrated Genomic Analysis of Sézary Syndrome
por: Mao, Xin, et al.
Publicado: (2011)

A mouse model for the Sézary syndrome
por: Doebbeling, Udo
Publicado: (2010)

Impressive Continuous Complete Response after Mogamulizumab in a Heavily Pretreated Sézary Syndrome Patient
por: Lolli, Ginevra, et al.
Publicado: (2020)

Sézary Syndrome with CD4/CD8 Double-Negative Neoplastic T Cells in Peripheral Blood
por: Kageyama, Yuki, et al.
Publicado: (2021)

Rescue therapy with alemtuzumab in B cell/antibody-mediated multiple sclerosis
por: Akgün, Katja, et al.
Publicado: (2018)

Failure of alemtuzumab therapy in three patients with MOG antibody associated disease
por: Seneviratne, Sinali O., et al.
Publicado: (2022)

Renal-Limited Antiglomerular Basement Membrane Disease Related To Alemtuzumab: A Case Report
por: Harrigan, Amye M., et al.
Publicado: (2020)

The utility of bexarotene in mycosis fungoides and Sézary syndrome
por: Panchal, Manisha R, et al.
Publicado: (2015)

Sezary syndrome manifesting as posttransplant lymphoproliferative disorder
por: Afiat, Thanh-Phuong, et al.
Publicado: (2018)

The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome
por: Miyashiro, Denis, et al.
Publicado: (2022)

TOX Expression in Mycosis Fungoides and Sezary Syndrome
por: Pileri, Alessandro, et al.
Publicado: (2022)

A case of autoimmune myositis after treatment with alemtuzumab for multiple sclerosis
por: Aouad, Patrick, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f2cggdg7kbnf8ck021hf1ddn4r